Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 12, 2012 - Issue 5
Submit an article Journal homepage
718
Views
30
CrossRef citations to date
0
Altmetric
Review

Demand for male contraception

Emily Dorman Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Suite E4622, Baltimore, MD 21205, USA
&
David Bishai Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Suite E4622, Baltimore, MD 21205, USA. [email protected]
Pages 605-613 | Published online: 09 Jan 2014

References

  • Smith PE. The disabilities caused by hypophysectomy and their repair: the tuberal (hypothalamic) syndrome in the rat. JAMA. 88, 158–161 (1927).
  • McCullagh EP, McGurl FJ. Further observation on the clinical use of testosterone propionate. J. Urol. 42, 1256–1267 (1939).
  • Heckel NJ. Production of oligospermia in a man by the use of testosterone propionate. Proc. Soc. Exp. Biol. Med. 40, 658–659 (1939).
  • WHO Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336, 955–959 (1990).
  • WHO Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil. Steril. 65, 821–829 (1996).
  • Diczfalusy E. World Health Organization special programme of research, development, and research training in human reproduction. The first fifteen years: a review. 34(1), 113–119 (1986).
  • Wu FCW. Male contraception. Baillieres Clin. Obstet. and Gynaecol. 10(1), 1–23. (1996).
  • Lyttle CR, Kopf GS. Status and future direction of male contraceptive development. Curr. Opin. Pharmacol. 3(6), 667–671 (2003).
  • Walton M, Anderson RA. Hormonal contraception in men. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5(3), 249–257 (2005).
  • Song L, Gu Y, Lu W, Liang X, Chen Z. A phase II randomized controlled trial of a novel male contraception, an intra-vas device. Int. J. Androl. 29(4), 489–495 (2006).
  • Chaudhury K, Bhattacharyya AK, Guha SK. Studies on the membrane integrity of human sperm treated with a new injectable male contraceptive. Hum. Reprod. 19(8), 1826–1830 (2004).
  • Darszon A, López-Martínez P, Acevedo JJ, Hernández-Cruz A, Treviño CL. T-type Ca2+ channels in sperm function. Cell Calcium 40(2), 241–252 (2006).
  • Amobi NI, Chung IP, Smith IC. Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors. Auton. Autacoid Pharmacol. 26(2), 169–181 (2006).
  • Cheng CY, Mruk DD. New frontiers in nonhormonal male contraception. Contraception 82(5), 476–482 (2010).
  • Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ. A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men. J. Clin. Endocrinol. Metab. 84(10), 3642–3647 (1999).
  • Page ST, Amory JK, Bremner WJ. Advances in male contraception. Endocr. Rev. 29(4), 465–493 (2008).
  • Handelsman DJ. Editorial: Hormonal male contraception – lessons from the east when the western market fails. J. Clin. Endocrinol. Metab. 88(2), 559–561 (2003).
  • Potts M. The myth of a male pill. Nat. Med. 2(4), 398–399 (1996).
  • Gu YQ, Wang XH, Xu D et al. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J. Clin. Endocrinol. Metab. 88(2), 562–568 (2003).
  • Turner L, Conway AJ, Jimenez M et al. Contraception efficacy of a depot progestin and androgen combination in men. J. Clin. Endocrinol. Metab. 88, 4659–4667 (2003).
  • Amory JK, Page ST, Bremner WJ. Drug insight: Recent advances in male hormonal contraception. Nat. Clin. Pract. Endocrinol. Metab. 2(1), 32–41 (2006).
  • Schearer BS, Alvarez-Sanchez F, Anseimo J et al. Hormonal contraception for men. Int. J. Androl. 1(2b), 680–712 (1978).
  • Mruk DD, Cheng CY. Delivering non-hormonal contraceptives to men: advances and obstacles. Trends Biotechnol. 26(2), 90–99 (2008).
  • Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C; Hormonal Male Contraception Summit Group. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet 367(9520), 1412–1420 (2006).
  • Matthiesson KL, McLachlan RI. Male hormonal contraception: concept proven, product in sight? Hum. Reprod. Update 12(4), 463–482 (2006).
  • Waites GMH. Development of methods of male contraception: impact of the World Health Organization Task Force. Fertil. Steril. 80(1) (2003).
  • Wu FC. Hormonal approaches to male contraception: approaching reality. Mol. Cell. Endocrinol. 250(1-2), 2–7 (2006).
  • Ringheim K. Whither methods for men? Emerging gender issues in contraception. Reprod. Health Matters. 7, 79–89 (1996).
  • Glasier A. Acceptability of contraception for men: a review. Contraception 82(5), 453–456 (2010).
  • Amory JK, Page ST, Anawalt BD, Matsumoto AM, Bremner WJ. Acceptability of a combination of testosterone gel and depomedroxyprogesteroneacetate male contraceptive regimen. Contraception 75, 218–223 (2007).
  • Meriggiola MC, Cerpolini S, Bremner WJ et al. Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. Hum. Reprod. 21(8), 2033–2040 (2006).
  • Zhang L, Shah IH, Liu Y, Vogelsong KM, Zhang L. The acceptability of an injectable, once-a-month male contraceptive in China. Contraception 73(5), 548–553 (2006).
  • Martin CW, Anderson RA, Cheng L et al. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum. Reprod. 15(3), 637–645 (2000).
  • Glasier AF, Anakwe R, Everington D et al. Would women trust their partners to use a male pill? Hum. Reprod. 15(3), 646–649 (2000).
  • Weston GC, Schlipalius ML, Bhuinneain MN, Vollenhoven BJ. Will Australian men use male hormonal contraception? A survey of a postpartum population. Med. J. Aust. 176(5), 208–210 (2002).
  • Singh S, Darroch JE, Ashford LS, Vlassoff M. Adding it up: the costs and benefits of investing in family planning and maternal and newborn health. Guttmacher Institute and United Nations Population Fund (2003).
  • United Nations, Population Division. World contraceptive use 2011, wall chart. Department of Economic and Social Affairs, Population Division (2011).
  • Vaughan B, Trussell J, Kost K, Singh S, Jones R. Discontinuation and resumption of contraceptive use: results from the National Survey of Family Growth. Contraception 78, 271–283 (2008).
  • United Nations. Levels and trends of contraceptive use as assessed in 1998. New York Department of International Economic and Social Affairs (2000).
  • National Vital Statistics Reports. Births: preliminary data for 2009. Natl. Vital. Stat. Rep. 59(3) (2010).
  • United States Department of Health and Human Services. Child support enforcement FY 2010 preliminary report. Administration for Children and Families, Office of Child Support Enforcement (2001).
  • United States Department of Health and Human Services. Child support enforcement FY 2010 preliminary report. Administration for Children and Families (2011).
  • Walsh TL, Frezieres RG, Peacock K et al. Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials. Contraception 70(5), 407–413 (2004).
  • Heinemann K, Saad F, Wiesemes M, White S, Heinemann L. Attitudes toward male fertility control: results of a multinational survey on four continents. Hum. Reprod. 20(2), 549–556 (2005).
  • Walker SZ. Attitudes to a male contraceptive pill in a group of contraceptive users in the UK. J. Men’s Health 8(4), 267–273 (2011).
  • Marcell AV, Plowden K, Bowman SM. Exploring older adolescents’ and young adults’ attitudes regarding male hormonal contraception: application for clinical practice. Hum. Reprod. 20(11), 3078–3084 (2005).
  • Chandra A, Martinez GM, Mosher WD et al. Fertility, contraception, and fatherhood: data on men and women from Cycle 6 (2002) of the national survey of family growth. National Center for Health Statistics. Vital Health Stats. 23(26) (2005).
  • United Nations. World contraceptive use 2011. Department of Economic and Social Affairs, Population Division (2011).
  • United Nations. World population prospects, the 2004 revision, volume II: sex and age. UN Econ. and Soc. Affairs (2004).
  • Marsiglio W, Menaghan EG. Couples and the male birth control pill: a future alternative in contraceptive solutions. J. Sex Research 23(1), 34–49 (1987).
  • Grady WR, Tanfer K, Billy JO, Lincoln-Hanson J. Men’s perceptions of their roles and responsibilities regarding sex, contraception and childrearing. Fam. Plann. Perspect. 28(5), 221–226 (1996).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.